Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Insecticide danger to bees addressed
European report looks at chemical risk

A report by the European Food Safety Authority (EFSA) has deemed the world's most widely-used insecticide an unacceptable danger to bees.

The report was demanded by the European commission in April, following two major studies earlier in the spring that found a link between the use of neonicotinoids and the UK's decline in bees. Further studies have been produced since.

Bees and other pollinators are critical to one-third of all food, therefore, the report examined the risk posed by the chemicals, including the widely-used insecticide, imidacloprid.

Working together with experts from across Europe, EFSA's report concluded that the use of imidacloprid would only be considered acceptable on crops that honeybees are not attracted to.

EFSA added that it found a widespread lack of information in many areas, earlier stating that current "simplistic" regulations contained "major weaknesses".

Andrew Pendleton, of Friends of the Earth, said: "This is a major turning point in the battle to save our bees. EFSA have sounded the death knell for one of the chemicals most frequently linked to bee decline and cast serious doubt over the safety of the whole neonicotinoid family."

However, a spokesperson for the company that produces imidaclopid, said: "The company is ready to work with the European commission and member states to address the perceived data gaps.

"We believe it is very important that any political decision relating to registrations of neonicotinoid-containing products should be based on clear, scientific evidence of adverse effects."

 

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.